Financials

  • Market Capitalization 134.61 M
  • Employee 9
  • Founded 2017
  • CEO N/A
  • Website www.nervgen.com
  • Headquarter British Columbia, Canada
  • FIGI BBG00NQ5C032
  • Industry N/A

Related tickers

#NamePrice24h %7d %1M %1Y %Market CapLast 7 Days
3771
FLX
BingEx Limited - American Depositary Shares
2.18 USD+1.40%+2.83%-2.24%-13.83%159.42 M USD
3850
MSLE
Satellos Bioscience Inc. - Common Stock
8.69 USD-3.55%-3.23%+50.87%-25.41%134.34 M USD
3994
EDHL
Everbright Digital Holding Limited - Ordinary Shares
3.53 USD-3.02%-25.84%-49.57%+390.28%94.11 M USD
4019
BCIC
BCP Investment Corporation - Closed End Fund
7.41 USD+1.51%+2.21%-0.13%-39.26%91.72 M USD

Frequently asked questions about NervGen Pharma Corp. - Common stock

What is the NervGen Pharma Corp. - Common stock stock price today?

The current price of NervGen Pharma Corp. - Common stock (NGEN) is 1.69. Over the past 24 hours, the stock has changed by -2.87%. Follow the NGEN chart for real-time price dynamics.

What is the stock ticker of NervGen Pharma Corp. - Common stock?

NervGen Pharma Corp. - Common stock trades under the ticker NGEN. Tickers can differ by exchange, so always check the exchange and instrument details before trading.

Is NervGen Pharma Corp. - Common stock stock going up?

NGEN has changed by -8.65% over the last week, -9.63% over the last month, and -73.17% over the last year. Review the chart to see whether the current move is part of a broader trend.

How many employees does NervGen Pharma Corp. - Common stock have?

As of the latest available data, NervGen Pharma Corp. - Common stock has 9 employees. Workforce size can provide additional context about the company's scale and operations.

How can I buy NervGen Pharma Corp. - Common stock stock?

You can buy NervGen Pharma Corp. - Common stock (NGEN) through a broker that provides access to the relevant stock exchange. Before trading, check commissions, execution conditions, account type, and whether the stock fits your investment plan.

Should I invest in NervGen Pharma Corp. - Common stock stock?

Investing in NervGen Pharma Corp. - Common stock requires reviewing its financial statements, valuation, earnings outlook, news, technical picture, and market risks. Use the NGEN chart and related analysis on metatrader.com as part of your research.